Minapharm Pharmaceuticals results, Fiscal year 2020
Net profit, assets, equity and cash flow for Fiscal year 2020, against the same period a year earlier, from the published financial statements.
Net profit301 millionEGP
Total assets3.48 billionEGP
Shareholders' equity1.59 billionEGP
Operating cash flow437 millionEGP
In short
- Minapharm Pharmaceuticals's net profit for Fiscal year 2020 was about 301 million EGP.
- Total assets at the end of Fiscal year 2020 were about 3.48 billion EGP, and shareholders' equity about 1.59 billion EGP.
- Operating cash flow for Fiscal year 2020 was positive at 437 million EGP.
Key lines against the same period a year earlier
This periodYear earlierChange
Net profit301 million——
Gross profit985 million——
Total assets3.48 billion——
Total liabilities1.89 billion——
Shareholders' equity1.59 billion——
Total liabilities and equity3.48 billion——
Operating cash flow437 million——
Investing cash flow-148 million——
Financing cash flow-26.73 million——
Net change in cash263 million——
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version.
Minapharm Pharmaceuticals's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy